Related Experiment Videos
Phase II trial of epirubicin at standard dose in relapsed ovarian cancer
European Journal of Cancer (Oxford, England : 1990)
|May 1, 1996
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Valorization of a subutilized by-product of the yerba mate industry to design active packaging material based on gelatin.
International journal of biological macromolecules·2025
Pandemic preparedness from the perspective of Occupational Health professionals.
Occupational medicine (Oxford, England)·2023
Effects of endocrine disorders on maxillary and mandibular growth in Colombian children and adolescents: a cross-sectional study.
European archives of paediatric dentistry : official journal of the European Academy of Paediatric Dentistry·2023
Ligand and metal-centred reactivity in 2,6-bis(imino)-1,4-dihydropyridinate Zn(II) alkyls: the dual behaviour of an intriguing type of complex.
Dalton transactions (Cambridge, England : 2003)·2023
Impact of Zulla cover crop in vineyard on the musts volatile profile of Vitis vinifera L. cv Syrah.
Food research international (Ottawa, Ont.)·2022
Unsupervised Quark/Gluon Jet Tagging With Poissonian Mixture Models.
Frontiers in artificial intelligence·2022
What does addressing cancer inequalities really mean? Five principles that can drive global action.
European journal of cancer (Oxford, England : 1990)·2026
Acute and long-term outcomes of CD20-targeting CAR T-cell therapy in relapsed or refractory B-NHL: MB-CART20.1 Lymphoma phase I trial.
European journal of cancer (Oxford, England : 1990)·2026
Combined pharmacologic and lifestyle intervention for breast cancer prevention: Results of the randomized phase II TOLERANT trial in high-risk women.
European journal of cancer (Oxford, England : 1990)·2026
Systemic inflammation and patient-reported quality of life as combined prognosticators in patients with solid tumors.
European journal of cancer (Oxford, England : 1990)·2026
Analysis of quality-adjusted time without symptoms or toxicity (Q-TWiST) in patients with metastatic hormone-sensitive prostate cancer from the ARASENS trial.
European journal of cancer (Oxford, England : 1990)·2026
Lazertinib plus pemetrexed and carboplatin in patients with EGFR-mutant advanced non-small cell lung cancer after progression on lazertinib.
European journal of cancer (Oxford, England : 1990)·2026
Liver-resident cellular determinants of oncolytic virotherapy in hepatocellular carcinoma: viral susceptibility and spatial immune remodeling.
Frontiers in cell and developmental biology·2026
Chemokines as regulators of CAR-T cell trafficking, function, and context-dependent tumor cell death.
Frontiers in immunology·2026
Efficacy of the Peritoneovenous Shunt as Palliative Care for Patients with Advanced Cancer with Refractory Ascites: A Randomized Controlled Trial (JIVROSG-0803 Study).
Interventional radiology (Higashimatsuyama-shi (Japan)·2026